Kurt F. Somerville’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-9,020
| Closed | -$460K | – | 106 |
|
|
2017
Q1 | $460K | Sell |
9,020
-6,117
| -40% | -$312K | 0.1% | 78 |
|
|
2016
Q4 | $565K | Buy |
15,137
+5
| +0% | +$187 | 0.13% | 75 |
|
|
2016
Q3 | $1.02M | Hold |
15,132
| – | – | 0.22% | 62 |
|
|
2016
Q2 | $840K | Buy |
15,132
+2
| +0% | +$111 | 0.19% | 62 |
|
|
2016
Q1 | $949K | Sell |
15,130
-80
| -0.5% | -$5.02K | 0.22% | 61 |
|
|
2015
Q4 | $1.43M | Buy |
15,210
+2,293
| +18% | +$216K | 0.33% | 55 |
|
|
2015
Q3 | $1.04M | Sell |
12,917
-310
| -2% | -$24.9K | 0.26% | 58 |
|
|
2015
Q2 | $1.59M | Sell |
13,227
-160
| -1% | -$19.2K | 0.37% | 51 |
|
|
2015
Q1 | $1.4M | Buy |
13,387
+105
| +0.8% | +$11K | 0.32% | 56 |
|
|
2014
Q4 | $1.29M | Buy |
13,282
+6,965
| +110% | +$675K | 0.32% | 56 |
|
|
2014
Q3 | $493K | Hold |
6,317
| – | – | 0.2% | 71 |
|
|
2014
Q2 | $400K | Sell |
6,317
-475
| -7% | -$30.1K | 0.16% | 81 |
|
|
2014
Q1 | $456K | Sell |
6,792
-6,693
| -50% | -$449K | 0.18% | 77 |
|
|
2013
Q4 | $867K | Sell |
13,485
-738
| -5% | -$47.4K | 0.33% | 57 |
|
|
2013
Q3 | $910K | Hold |
14,223
| – | – | 0.36% | 57 |
|
|
2013
Q2 | $440K | Buy |
+14,223
| New | +$440K | 0.18% | 77 |
|